D.E. Shaw & Co’s Acumen Pharmaceuticals ABOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-55,007
| Closed | -$133K | – | 3124 |
|
|
2024
Q2 | $133K | Buy |
+55,007
| New | +$133K | ﹤0.01% | 2870 |
|
|
2024
Q1 | – | Sell |
-138,029
| Closed | -$530K | – | 3098 |
|
|
2023
Q4 | $530K | Buy |
+138,029
| New | +$530K | ﹤0.01% | 2344 |
|
|
2023
Q3 | – | Sell |
-60,504
| Closed | -$291K | – | 3031 |
|
|
2023
Q2 | $291K | Sell |
60,504
-99,704
| -62% | -$480K | ﹤0.01% | 2494 |
|
|
2023
Q1 | $650K | Sell |
160,208
-81,633
| -34% | -$331K | ﹤0.01% | 2402 |
|
|
2022
Q4 | $1.31M | Buy |
241,841
+77,199
| +47% | +$417K | ﹤0.01% | 2273 |
|
|
2022
Q3 | $1.65M | Buy |
164,642
+146,065
| +786% | +$1.46M | ﹤0.01% | 2235 |
|
|
2022
Q2 | $87K | Sell |
18,577
-29,599
| -61% | -$139K | ﹤0.01% | 3578 |
|
|
2022
Q1 | $188K | Buy |
48,176
+21,009
| +77% | +$82K | ﹤0.01% | 3637 |
|
|
2021
Q4 | $184K | Buy |
27,167
+8,853
| +48% | +$60K | ﹤0.01% | 3510 |
|
|
2021
Q3 | $272K | Buy |
+18,314
| New | +$272K | ﹤0.01% | 3112 |
|